Thursday, March 13, 2014 | 8:00 AM - 7:00 PM
Keynote Speaker: Kelly Tappenden (University of Illinois)
Speakers: Marian de van der Schueren (VU University Medical Center, Amsterdam), Marinos Elia (University of Southampton), Leah Gramlich (Alberta Health Services North), Michael Johnson (Bayada Home Healthcare), Su Lin Lim (National University Hospital, Singapore), Hélène Payette (Université de Sherbrooke), Tomas Philipson (University of Chicago), Carla Prado (Florida State University)
The conference will focus on malnutrition's clinical and economic impacts of prevention across the continuum of care; new approaches and interventions to integrated care; and, a health systems approach to delivery of nutrition interventions.
March 15 - 17, 2014 | Qatar
Featuring: Huda Akil (University of Michigan), Karl Deisseroth (Stanford University)
Join global experts in clinical neuroscience in Doha, Qatar, for a 2.5 day, two-track conference that will feature recent advances in the understanding and treatment of mood disorders, stroke, and traumatic brain injury.
Monday, March 24, 2014 | 8:00 AM - 5:00 PM
Speakers: David Alland (Rutgers New Jersey Medical School), Stephanie Boisson-Dupuis (The Rockefeller University), Andrea M. Cooper (Trudeau Institute), Jerrold J. Ellner (Boston Medical Center), Daniel E. Everitt (TB Alliance), Michael S. Glickman (Memorial Sloan-Kettering Cancer Center), Kathleen A. McDonough (Wadsworth Center ), Steven A. Porcelli (Albert Einstein College of Medicine), Kyu Rhee (Weill Cornell Medical College), G. Marcela Rodriguez (Rutgers New Jersey Medical School), Padmini Salgame (Rutgers New Jersey Medical School), Marie Samanovic (NYU Langone Medical Center), Jessica C. Seeliger (Stony Brook University)
TB is a curable infection that should be a disease of the past, yet a third of the world's population remains affected. Join us on World TB Day to explore scientific insights towards novel diagnostics, therapeutics and vaccine-related tools.
Tuesday, March 25, 2014 | 12:00 PM - 4:00 PM
Speakers: Rolf Brekken (UT Southwestern), Jessica S. Donington (NYU Langone Medical Center), Balazs Halmos (Columbia University Medical Center), Roy S. Herbst (Yale School of Medicine), Suresh S. Ramalingam (Emory University)
Recent treatment advances may improve lung cancer patient survival rates, as understanding genetic heterogeneity can improve trial patient selection. Hear updates on common mutations, intraoperative chemotherapy, and insights from clinical trials.
Tuesday, April 8, 2014 | 8:30 AM - 4:30 PM
Speakers: Dan V. Iosifescu (Icahn School of Medicine at Mount Sinai), Daniel C. Javitt (Columbia University and Nathan Kline Institute), John H. Krystal (Yale University), Andrew F. Leuchter (University of California, Los Angeles), Gregory Light (University of California, San Diego), Siva Digavalli (Bristol-Myers Squibb), Eva Redei (Northwestern University), Steven J. Siegel (University of Pennsylvania)
Recent breakthrough insights from clinical studies are illuminating the neurobiology of psychiatric disorders. This symposium explores differences in sensory processing, imaging, and other biomarkers that may translate findings to animal models.
Tuesday, February 18, 2014 | 8:30 AM - 4:30 PM
Speakers: John DiPersio (Washington University School of Medicine), William R. Drobyski (Medical College of Wisconsin), James Ferrara (University of Michigan), David L. Porter, MD, University of Pennsylvania Medical Center, Robert J. Soiffer (Dana-Farber Cancer Institute), Megan Sykes (Columbia University), Marcel RM van den Brink (Memorial Sloan Kettering Cancer Center)
Mechanisms that cause graft-versus-host disease (GvHD), a major cause of mortality after stem cell transplants, must be inhibited while preserving the graft-versus-tumor (GvT) response. Explore recent advances in separating GvHD from GvT effects.
Tuesday, January 28, 2014 | 8:30 AM - 4:30 PM
Speakers: Nahor Haddish-Berhane (Pfizer), Sara Hurvitz (UCLA Medical Center), Omar Kabbarah (Genentech Inc.), Peter D. Senter (Seattle Genetics, Inc.), Dhaval K. Shah (The State University of New York at Buffalo), Stacey S. Shord (Food and Drug Administration), Melissa M. Schutten (Genentech Inc.), and Puja Sapra (Pfizer), Alan Wahl (Ambrx)
Antibody-drug conjugates (ADCs) promise safer, more effective therapies than standard anti-cancer drugs. This symposium highlights linker-payload and coupling chemistries, ADC development, biomarker and patient selection, and regulatory perspectives.
Tuesday, December 10, 2013 | 8:30 AM - 4:30 PM
Speakers: Frank M. LaFerla (University of California, Irvine), Sylvain E. Lesné (University of Minnesota), Bingwei Lu (Stanford University School of Medicine), Lennart Mucke (Gladstone Institute of Neurological Disease), Ralph A. Nixon (Nathan Kline Institute), Franck Polleux (Columbia University), Terrence Town (University of Southern California), Tony Wyss-Coray (Stanford University School of Medicine)
Organizers: Ken Jones (Forest Research Institute), Robert Martone (Covance Biomarker Center of Excellence),
Robert B. Nelson (Lundbeck Research USA), Jennifer Henry (The New York Academy of Sciences)
This symposium explores how efforts to better integrate our understanding of neuritic plaques and neurofibrillary tangles—the two hallmark pathologies of Alzheimer's disease—are leading to a 'truce' between former rivals in the quest for therapies.
Thursday, November 14, 2013 | 12:00 PM - 4:00 PM
Keynote Speaker: Nancy J. Cox (Centers for Disease Control and Prevention)
Speakers: Kathy Coelingh (MedImmune), Manon M. J. Cox (Protein Sciences), Ruben Donis (Centers for Disease Control and Prevention), Philip R. Dormitzer (Novartis Vaccines and Diagnostics), David P. Greenberg (Sanofi Pasteur US)
Evolution of the influenza virus and emergence of new viruses from animals pose a continuing challenge. H7N9, H1N1pdm and H5N1 are all sources of ongoing concern. Explore quadrivalent vaccines, efforts to boost efficacy, and recent FDA approvals.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents four scholarly reports: (1) Effects of Genetic, Processing, or Product Formulation Changes on Efficacy and Safety of Probiotics; (2) Probiotics and Prebiotics: Prospects for Public Health and Nutritional Recommendations; (3)Targeting Epigenetic Regulators for Cancer Therapy; and (4) Précis of Nutrition of Children and Women in Haiti: Analyses of Data from 1995 to 2012.
Organizers: Mandë Holford (Hunter College, CUNY; American Museum of Natural History), Steven Gross (Weill Cornell Medical College), and Jennifer Henry (The New York Academy of Sciences)
Keynote Speaker: Baldomero M. Olivera (University of Utah)
Venomous animals, including spiders, snakes, scorpions, sea snails, leeches, and others, produce millions of bioactive compounds, offering enormous potential for venom-based drug discovery.
Organizers: John E. Hambor (Boehringer-Ingelheim Pharmaceuticals) and Jennifer Henry (The New York Academy of Sciences)
Dendritic cells offer promise in the development of cancer vaccines.
Organizers: Katalin Kauser (Bayer HealthCare), Scott MacDonnell (Boehringer-Ingelheim Pharmaceuticals), Silvia Pomposiello (F. Hoffmann-La Roche), Carolyn Foster, and Jennifer Henry (The New York Academy of Sciences)
Fibrosis is common in chronic organ injury, leading to progressive life-threatening outcomes. This eBriefing reviews the link between fibrosis and disease and explores how to use biomarkers and imaging to translate laboratory results into clinical success.
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.